Anthem Teams With CVS to Start Its Own Pharmacy
Anthem announced on Wednesday that it will start its own business to manage prescripton drug plans by partnering with CVS Health, reported The New York Times. The insurance company said that it will begin its new business in 2020 after its contract with Express Scripts expires. Anthem is currently in the middle of a legal battle with Express Scripts over their claims that they have been overcharged. It is estimated that the savings from the new partnership will be around $4 billion a year, the majority of which will affect customers in the form of lower drug costs, the insurance company said.
Former Pharma Exec Being Eyed for Health Secretary
Alex Azar, a former pharmaceutical executive at Eli Lilly and George W. Bush administration official, is the front-runner to replace Tom Price as HHS secretary, reported Politico. Price resigned in September following reports that he spent over $1 million of taxpayer money on private and government planes for travel. Azar had spent the past decade in the drug industry until leaving the company in January. He has been a harsh critic of ObamaCare and voiced approval for GOP efforts to repeal and replace it.
Trump Gives Mixed Signals on Senate Deal to Fund Health Subsidies
President Trump expressed opposition to the bipartisan senate proposal that would stabilize health insurance markets on Wednesday, according to The New York Times. This opposition comes just a day after he appeared to give his blessing for the deal. The deal made on Tuesday will fund critical subsidies to insurers, which President Trump had cut off just days before, for 2 years. White House press secretary Sarah Huckabee Sanders later said that President Trump does not support the bill in its current form but indicated that changes could win him over.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More